EDGAR Filing Documents for 0001193125-10-279912

Form 8-K - Current report:

SEC Accession No. 0001193125-10-279912

Filing Date

2010-12-14

Accepted

2010-12-14 09:40:40

Documents

Period of Report

2010-12-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	18940
2	OPINION OF CHOATE, HALL & STEWART LLP	dex51.htm	EX-5.1	5906
3	FORM OF SUBSCRIPTION AGREEMENT	dex101.htm	EX-10.1	45160
4	AMENDMENT NUMBER FOUR TO ANTIGENICS INC. DIRECTORS' DEFERRED COMPENSATION PLAN	dex102.htm	EX-10.2	9052
	Complete submission text file	0001193125-10-279912.txt		80750

Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010

Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200

ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)